When I look back on my life of nearly 60 years, I am struck by how much of that life has been focused on the care of others around me. The people I’ve cared for are a varied group ranging from the teams that reported…
A new model of nerve fibers may serve as a platform to screen for experimental treatments that can promote myelin repair in multiple sclerosis (MS), a study showed. The model is made of soft micropillars around which myelin-producing cells can wrap myelin. Researchers found that…
Quantum Biopharma has officially filed with the U.S. Food and Drug Administration (FDA) for clearance to begin a Phase 2 clinical trial of Lucid-MS, a “first-in-class” oral therapy designed to halt the progression of multiple sclerosis (MS) by protecting myelin, or the protective sheath around…
Tweet Progression independent of relapse (clinical & Imaging) drives disability and is the basis for progression of disability. Natalizumab has its main action outside of the brain so any influence on progression would be due to stopping the consequences of damaging immune attack from entering…